Atossa Therapeutics Inc (NASDAQ:ATOS) traded at $1.50 at last check on Tuesday, April 30, made a downward move of -1.96% on its previous day’s price.
Looking at the stock we see that its previous close was $1.53. In terms of its 52-week price range, ATOS has a high of $2.31 and a low of $0.60. The company’s stock has lost about -25.00% over that past 30 days.
Atossa Therapeutics Inc has a market cap of $187.95 million. Estimates by analysts give the company expected earnings per share (EPS) of -$0.06, with the EPS growth for the year raised at -$0.27 for 2024 and -$0.3 for next year. These figures represent -12.50% and -11.10% growth in EPS for the two years respectively.
On the other hand, looking at the outlook for the ATOS stock, short term indicators assign the stock an average of 50% Buy, while medium term indicators assign it an average of 100% Buy. Long term indicators on average place the stock in the category of 100% Buy.
Looking further, we note the current price level is -9.05% off its SMA20 and 4.47% from its 50-day simple moving average. The RSI (14) is pointing at 47.47 while the volatility over the past week is 6.54% and jumps to 12.77% over the past one month. The beta value is 1.27, while the average true range (ATR) is currently pointing at 0.16.
Coming back to Atossa Therapeutics Inc (NASDAQ:ATOS), we note that the average 3-month trading volume was 1.70 million. Current shares outstanding are 125.30 million.
The insiders hold 0.04% of the company’s shares while institutions hold 12.97%. Investors should be excited about this stock as its upside potential is great, with today’s price pushing the stock 70.45% up in year-to-date price movement.
